Results 311 to 320 of about 1,251,677 (333)

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Tissue factor pathway inhibitor and the revised theory of coagulation.

Annual Review of Medicine, 1995
G. Broze
semanticscholar   +1 more source

The adenosine pathway in immuno-oncology

Nature Reviews Clinical Oncology, 2020
Bertrand Allard, Laurence Buisseret, John Stagg   +2 more
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Lineage plasticity in cancer: a shared pathway of therapeutic resistance

Nature Reviews Clinical Oncology, 2020
Helena A Yu, Dana Pe'er, Charles L Sawyers   +2 more
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Materials design for bone-tissue engineering

Nature Reviews Materials, 2020
Mani Diba, Antonios G Mikos
exaly  

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies

Ca-A Cancer Journal for Clinicians, 2016
Adam S Baumgarten, Anna R Giuliano
exaly  

Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.

Biochemistry, 1996
Lars C. Petersen, C. Sprecher, D. Foster, H. Blumberg, T. Hamamoto, Walter Kisiel   +5 more
semanticscholar   +1 more source

Recent developments in the medical and surgical treatment of melanoma

Ca-A Cancer Journal for Clinicians, 2014
Jonathan S Zager
exaly